GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Net Interest Income (for Banks)

ME Therapeutics Holding (XCNQ:METX) Net Interest Income (for Banks)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.